$ 20.23
Key Takeaways
Risk factor
Strong trading liquidity
Profitability factor
Very low or no dividends
About
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures,...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, overvalued on EV/E
Target Price
The average target price of TEVA is 24 and suggests 20% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
